PUMA BIOTECHNOLOGY, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2011-12-01: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2011-11-18; Total offering amount $4,999,751.
- 2011-10-12: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2011-10-04; Total offering amount $70,000,249.
- 2011-10-04: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2011-10-04; Total offering amount $70,000,249.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2011-12-01 | Rule 506 | Equity | 2011-11-18 | $4,999,751 | $4,999,751 | $0 | 139 |
| 2011-10-12 D/A | Rule 506 | Equity | 2011-10-04 | $70,000,249 | $70,000,249 | $0 | 28 |
| 2011-10-04 | Rule 506 | Equity | 2011-10-04 | $70,000,249 | $70,000,249 | $0 | 15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |